Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Shinder

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|January 10, 2018
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkersIzak Faiena, Sinae Kim, Nicholas Farber, et al.
The Canadian Journal of Urology|October 4, 2017
Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patientsNicholas J Farber, Rachel B Davis, Gwen M Grimsby, et al.
Asian Journal of Andrology|April 26, 2017
Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional studyDae Keun Kim, Jaspreet Singh Parihar, Young Suk Kwon, et al.
Urologic Oncology|November 23, 2020
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyondArnav Srivastava, Hiren V Patel, Sinae Kim, et al.
Urologic Oncology|November 18, 2018
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer DatabaseNicholas J Farber, Zorimar Rivera-Núñez, Sinae Kim, et al.
Prostate Cancer and Prostatic Diseases|March 21, 2018
Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerBenjamin Benzon, Stephanie A Glavaris, Brian W Simons, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|January 10, 2018
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkersIzak Faiena, Sinae Kim, Nicholas Farber, et al.
The Canadian Journal of Urology|October 4, 2017
Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patientsNicholas J Farber, Rachel B Davis, Gwen M Grimsby, et al.
Asian Journal of Andrology|April 26, 2017
Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional studyDae Keun Kim, Jaspreet Singh Parihar, Young Suk Kwon, et al.
Urologic Oncology|November 23, 2020
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyondArnav Srivastava, Hiren V Patel, Sinae Kim, et al.
Urologic Oncology|November 18, 2018
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer DatabaseNicholas J Farber, Zorimar Rivera-Núñez, Sinae Kim, et al.
Prostate Cancer and Prostatic Diseases|March 21, 2018
Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerBenjamin Benzon, Stephanie A Glavaris, Brian W Simons, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.
Pageof 2